Glatiramer | High Purity Peptide | CAS No. 28704-27-0

Glatiramer | High Purity Peptide | CAS No. 28704-27-0

Glatiramer (CAS No. 28704-27-0) is a synthetic polypeptide composed of four amino acids: L-glutamic acid, L-lysine, L-alanine, and L-tyrosine. It is used as an immunomodulatory agent in the treatment of multiple sclerosis (MS) by modifying immune responses and reducing autoimmune attacks on myelin in the central nervous system.
Send Inquiry
Description

Product Introduction

 

Glatiramer (CAS No. 28704-27-0) is a synthetic polypeptide composed of four amino acids: L-glutamic acid, L-lysine, L-alanine, and L-tyrosine. It is used as an immunomodulatory agent in the treatment of multiple sclerosis (MS) by modifying immune responses and reducing autoimmune attacks on myelin in the central nervous system. Our Glatiramer is produced using advanced solid-phase peptide synthesis (SPPS) combined with high-purity purification techniques, ensuring consistent batch quality, high stability, and suitability for pharmaceutical research, formulation development, and biomedical studies.

 

Product Parameters (Specification)

 

Parameter

Specification

Product Name

Glatiramer

CAS No.

28704-27-0

Molecular Formula

(C15H24N4O7)n (approximate, as polymer mixture)

Molecular Weight

~5000–9000 g/mol (depending on polymer length)

Appearance

White to off-white lyophilized powder

Purity (HPLC)

≥95% (by peptide content)

Storage

Store at -20°C, protected from light and moisture

Shelf Life

2 years under proper storage conditions

 

Product Features and Applications

 

  • Synthetic polypeptide prepared via advanced SPPS techniques.
  • Immunomodulatory agent used in the treatment of multiple sclerosis (MS).
  • Reduces autoimmune-mediated demyelination and inflammation in the CNS.
  • Suitable for pharmaceutical research, formulation development, and reference standard studies.
  • Can be used in preclinical studies, immunology research, and mechanistic investigations.

 

Production Details

 

Glatiramer is produced in GMP-compliant facilities using solid-phase peptide synthesis and high-purity purification methods. Each batch undergoes rigorous analytical testing including HPLC, MS, amino acid composition analysis, polymer length distribution, and moisture content to ensure identity, purity, and consistency.

 

Product Qualification

 

Our manufacturing facilities are ISO9001 and GMP certified. All peptide products are provided with comprehensive documentation including Certificate of Analysis (COA), MSDS, and analytical data. Third-party testing reports are available upon request.

 

Delivery, Shipping, and Service

Packaging

5mg, 10mg, 25mg, or customized sizes upon request.

Lead Time

Typically 3–5 business days after order confirmation.

Shipping

Express delivery via DHL, FedEx, or UPS with cold-chain protection.

Customer Service

Dedicated technical and after-sales support team available 24/7.

 

FAQ

 

Q1: Is Glatiramer for human use?

A: For research and pharmaceutical manufacturing use only, not for direct human administration.

Q2: How should Glatiramer be stored?

A: Keep in a tightly sealed vial at -20°C, protected from moisture and light.

Q3: Can analytical data be provided?

A: Yes, COA, HPLC, MS, and amino acid composition data accompany each batch shipment.

 

Latest News

 

We continuously invest in R&D for peptide synthesis, polymer characterization, and formulation technologies, ensuring the highest quality standards for our pharmaceutical-grade polypeptides. For more peptide innovations, please visit our official website.

 

Hot Tags: glatiramer | high purity peptide | cas no. 28704-27-0, China glatiramer | high purity peptide | cas no. 28704-27-0 manufacturers, suppliers